Table 1 (abstract O06). Median (range) IFN-gamma: CXCL9 and IL-18:CXCL9 ratios at baseline

pACR30 at day 15

2.54 (0.03-557.31)

0.34 (0.01-1.62)

0.004

5.27 (0.19-68.32)

0.82 (0.24-4.85)

0.003

pACR50 at day 15

2.37 (0.03-557.31)

0.36 (0.01-3.76)

0.010

5.23 (0.19-68.32)

1.35 (0.24-5.38)

0.007

pACR70 at day 15

2.54 (0.03-557.31)

0.57 (0.01-42.27)

0.052

5.27 (0.19-68.32)

1.56 (0.24-20.03)

0.015

pACR90 at day 15

3.69 (0.03-557.31)

0.57 (0.01-42.27)

0.006

7.51 (0.19-68.32)

1.88 (0.19-20.03)

0.002

pACR100 at day 15

3.99 (0.05-557.31)

0.57 (0.01-42.27)

0.001

8.35 (0.19-68.32)

1.97 (0.19-43.46)

0.002

CID at day 15

3.84 (0.03-557.31)

0.66 (0.01-42.81)

0.015

8.34 (0.62-68.32)

1.97 (0.19-41.52)

0.002

Sustained complete response

5.52 (0.03-557.31)

0.65 (0.01-277.69)

0.002

8.35 (0.62-68.32)

2.01 (0.19-43.46)

0.002